Search bioRxiv⌕ Search

Biology subjects

Henao, R.

Publications and source records attributed to Henao, R..

5 recordsLinked to original sources

Assessing Scale and Predictive Diversity in Models for Single-Cell Transcriptomics based on Geneformer

Foundation models are increasingly applied to single-cell transcriptomics, where they promise to capture generalizable representations that support diverse downstream analyzes. However, two central questions remain: Does scaling pre-training data reliably improve performance, and do models trained on rank-ordered expression profiles confer advantages for mitigating batch effects? We addressed these questions by systematically assessing transformer-based models pre-trained on ranked single-cell profiles with varying data scales. The models were evaluated on masked gene prediction and downstream tasks, including cell type classification, perturbation response prediction, and zero-shot batch integration. To complement prediction accuracy, we further quantified prediction repetition, uniqueness, and diversity. In addition, we evaluated architectural refinements that incorporate cumulative prediction adjustment and similarity-based regularization; however, the study mainly focused on comparative evaluations rather than the development of new models. Our results indicated that scaling pretraining corpora improved masked prediction accuracy but did not consistently enhance downstream performance. Smaller models often matched or exceeded larger ones, indicating diminishing returns relative to scale. Rank-based models offered limited robustness to batch effects and consistently underperformed relative to domain-specific correction methods. Across all scales, high redundancy in predicted genes remains a major limitation. Together, these findings challenge assumptions that larger datasets or rank-order modeling automatically confer stronger generalization. Progress in single-cell foundation models may depend less on scale and more on pre-training objectives that enhance predictive diversity and biological plausibility. Author summaryIn recent years, large machine learning models have been adapted to study single cells, raising hopes that simply training on more data would automatically lead to better biological insights. Our study aimed to test this assumption by carefully evaluating models trained on small versus very large collections of single-cell data. We also asked whether models that learn from ranked lists of gene expressions offer an advantage in correcting technical differences between experiments, a common challenge in biology. We found that bigger is not always better. Although larger models improved performance in predicting missing genes, this advantage did not consistently translate to stronger results in tasks such as cell type classification or data integration across studies. In fact, smaller models often matched or outperformed their larger counterparts. Models trained on ranked data were also not sufficient to reliably correct batch effects, and traditional tools still worked better for this purpose. Our findings suggest that future progress may come less from ever-larger models and more from rethinking how models learn from biological data. This work provides guidance for researchers designing new approaches and helps clarify realistic expectations for applying artificial intelligence to single-cell biology.

bioinformatics↗

TAMC: A deep-learning approach to predict motif-centric transcriptional factor binding activity based on ATAC-seq profile

Determining transcriptional factor binding sites (TFBSs) is critical for understanding the molecular mechanisms regulating gene expression in different biological conditions. Biological assays designed to directly mapping TFBSs require large sample size and intensive resources. As an alternative, ATAC-seq assay is simple to conduct and provides genomic cleavage profiles that contain rich information for imputing TFBSs indirectly. Previous footprint-based tools are inheritably limited by the accuracy of their bias correction algorithms and the efficiency of their feature extraction models. Here we introduce TAMC (Transcriptional factor binding prediction from ATAC-seq profile at Motif-predicted binding sites using Convolutional neural networks), a deep-learning approach for predicting motif-centric TF binding activity from paired-end ATAC-seq data. TAMC does not require bias correction during signal processing. By leveraging a onedimensional convolutional neural network (1D-CNN) model, TAMC captures both footprint and non-footprint features at binding sites for each TF and outperforms existing footprinting tools in TFBS prediction particularly for ATAC-seq data with limited sequencing depth. AUTHOR SUMMARYApplications of deep-learning models are rapidly gaining popularity in recent biological studies because of their efficiency in analyzing non-linear patterns from feature-rich data. In this study, we developed a 1D-CNN model to predict TFBSs from ATAC-seq data. Compared to previous models using scoring functions and classical machine learning algorithms, our 1D-CNN model forgoes the need for bias correction during signal processing and significantly increases the efficiency in extracting features for TFBS prediction. In addition, the performance of our 1D-CNN model improves when the sequencing depth of training ATAC-seq data increases. Importantly, we showed that our method outperforms existing tools in TFBS prediction particularly when the sequencing depth of training ATAC-seq data is higher than the ATAC-seq data for prediction. This widened the applicability of our model to ATAC-seq data with both deep and shallow sequencing depth. Based on these results, we discussed about the potential application of our method to TFBS predication using bulk and single-cell ATAC-seq data.

bioinformatics↗

Chromatin remodeling in peripheral blood cells reflects COVID-19 symptom severity

SARS-CoV-2 infection triggers highly variable host responses and causes varying degrees of illness in humans. We sought to harness the peripheral blood mononuclear cell (PBMC) response over the course of illness to provide insight into COVID-19 physiology. We analyzed PBMCs from subjects with variable symptom severity at different stages of clinical illness before and after IgG seroconversion to SARS-CoV-2. Prior to seroconversion, PBMC transcriptomes did not distinguish symptom severity. In contrast, changes in chromatin accessibility were associated with symptom severity. Furthermore, single-cell analyses revealed evolution of the chromatin accessibility landscape and transcription factor motif occupancy for individual PBMC cell types. The most extensive remodeling occurred in CD14+ monocytes where sub-populations with distinct chromatin accessibility profiles were associated with disease severity. Our findings indicate that pre-seroconversion chromatin remodeling in certain innate immune populations is associated with divergence in symptom severity, and the identified transcription factors, regulatory elements, and downstream pathways provide potential prognostic markers for COVID-19 subjects. One sentence summaryChromatin accessibility in immune cells from COVID-19 subjects is remodeled prior to seroconversion to reflect disease severity.

genomics↗

A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infection

Respiratory viruses are highly infectious; however, the variation of individuals physiologic responses to viral exposure is poorly understood. Most studies examining molecular predictors of response focus on late stage predictors, typically near the time of peak symptoms. To determine whether pre- or early post-exposure factors could predict response, we conducted a community-based analysis to identify predictors of resilience or susceptibility to several respiratory viruses (H1N1, H3N2, Rhinovirus, and RSV) using peripheral blood gene expression profiles collected from healthy subjects prior to viral exposure, as well as up to 24 hours following exposure. This analysis revealed that it is possible to construct models predictive of symptoms using profiles even prior to viral exposure. Analysis of predictive gene features revealed little overlap among models; however, in aggregate, these genes were enriched for common pathways. Heme Metabolism, the most significantly enriched pathway, was associated with higher risk of developing symptoms following viral exposure.

immunology↗

Mortality prediction in sepsis via gene expression analysis: a community approach

Improved risk stratification and prognosis in sepsis is a critical unmet need. Clinical severity scores and available assays such as blood lactate reflect global illness severity with suboptimal performance, and do not specifically reveal the underlying dysregulation of sepsis. Here three scientific groups were invited to independently generate prognostic models for 30-day mortality using 12 discovery cohorts (N=650) containing transcriptomic data collected from primarily community-onset sepsis patients. Predictive performance was validated in 5 cohorts of community-onset sepsis patients (N=189) in which the models showed summary AUROCs ranging from 0.765-0.89. Similar performance was observed in 4 cohorts of hospital-acquired sepsis (N=282). Combining the new gene-expression-based prognostic models with prior clinical severity scores led to significant improvement in prediction of 30-day mortality (p<0.01). These models provide an opportunity to develop molecular bedside tests that may improve risk stratification and mortality prediction in patients with sepsis, improving both resource allocation and prognostic enrichment in clinical trials.

bioinformatics↗